Stapled Peptide Library Design for Diverse Target Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing stapled peptide technologies are constrained to pre-selected amino acid sequences, limiting their ability to generate and analyze stapled peptides that bind to targets without known protein interaction partners or produce different biological outcomes.
Innovation Solution
The development of strategies and technologies for high-throughput generation and analysis of stapled peptides with diverse amino acid sequences, including cysteine stapling methods, to create peptides that can bind to targets with unique sequences and produce specific biological effects, using phage display systems and synthetic technologies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If pre-selected amino acid sequences are used in stapled peptide technologies, then the production process is simplified and more predictable, but the ability to generate peptides with diverse sequences that bind to novel targets is limited
Solution Approach 1:
The peptide library is segmented into multiple components: a fixed staple region providing structural consistency, and variable amino acid regions enabling sequence diversity. This segmentation allows the peptide to maintain manufacturability through the standardized staple portion while achieving versatility through the variable regions that can be customized for different target bindings
Solution Approach 2:
The stapled peptide platform is designed with universal features including a conserved staple chemistry and structural framework that can be applied across multiple peptide sequences. This universal backbone enables the same manufacturing and characterization protocols to be used for diverse peptide variants, maintaining ease of manufacture while achieving broad adaptability for binding to various targets including those without known interaction partners
2Adaptability or versatility
If high-throughput generation and analysis of stapled peptides with diverse sequences is implemented, then the ability to identify peptides binding to novel targets is improved, but the complexity of the system and processes increases
Solution Approach 1:
Staples are pre-installed at defined positions within the amino acid sequence before the high-throughput screening process. This preliminary structural configuration ensures that all peptide variants in the library share a common folded architecture and binding interface, reducing the complexity of analyzing diverse sequences by maintaining structural consistency across the library
Solution Approach 2:
The system employs controlled parameter changes by varying only the amino acid sequence parameters while keeping the staple position, chemistry, and overall peptide length parameters constant. This selective parameter variation allows high-throughput generation of sequence diversity without proportionally increasing system complexity, as the fixed parameters provide a standardized framework for screening and analysis
3Adaptability or versatility
If stapled peptides are designed to bind to targets different from natural interaction partners, then novel biological outcomes can be achieved, but the difficulty of identifying and characterizing useful sequences increases
Solution Approach 1:
The high-throughput screening system incorporates feedback mechanisms where binding data from initial screenings informs the design and prioritization of subsequent peptide variants. This iterative feedback loop allows the identification of useful sequences binding to novel targets by learning from previous results, progressively optimizing the search while managing characterization complexity through data-driven decision making
Data Source
AI summary
The present disclosure provides powerful technologies for the development, production, characterization, and/or use of stapled peptide compositions. Among other things, the present disclosure provides strategies for defining amino acid sequences particularly amenable or useful for stapling, as well as technologies, reagents, and systems for developing, producing, characterizing, and/or using stapled peptides having such amino acid sequences. In some embodiments, the present disclosure provides stapled peptide agents and uses thereof including for treating various conditions, disorders or diseases.